Key learning points: managing type 2 diabetes in adults
Dr Pam Brown and Dr Colin Kenny provide seven key learning points from the updated NICE guideline on the management of type 2 diabetes
Key learning points: defining remission in type 2 diabetes
Dr Pam Brown provides seven key learning points for primary care from a consensus report on defining remission in diabetes
Key learning points: diabetes and frailty in older adults
Dr David Strain outlines six key learning points from an expert consensus statement on managing diabetes and frailty, and identifies where treatment should differ from a standard approach
Tailor treatment of type 2 diabetes to improve cardiovascular outcomes
Karen Bartha discusses the Association of British Clinical Diabetologists position statement on the use of newer antidiabetic drugs in patients with cardiovascular disease
Manage diabetes and comorbidities with a joined-up strategy
Dr Umesh Dashora and colleagues from the CaReMeUK Partnership outline guidance on how to manage type 2 diabetes with cardiovascular and renal disease
Test and reflect
Our multiple-choice questions (MCQs) are designed to help you test your knowledge and reflect on your learning after reading an article.
Patient scenarios: update of NICE guidance on type 2 diabetes in adults
UK expert consensus statement on the management of older adults with diabetes
ABCD guideline on type 2 diabetes and cardiovascular outcomes
CaReMeUK guideline on the management of diabetes and comorbidities
Patient scenarios: CaReMeUK guidance on the management of diabetes and comorbidities
Educational resources
Guideline for the managed introduction of biosimilar bolus insulin in individuals with type 2 diabetes
This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Sanofi Ltd
Deep dive on DPP-4 inhibitors with a focus on Trajenta® (linagliptin)
This eLearning module and the associated videos have been commissioned and funded by Boehringer Ingelheim. The module and associated videos contain promotional content. For UK healthcare professionals.
View Trajenta® (linagliptin) prescribing and adverse event reporting information for Great Britain or Northern Ireland
View Jardiance® (empagliflozin) prescribing and adverse event reporting information for Great Britain or Northern Ireland
PC-GB-104526 July 2021
Guideline for the managed introduction of biosimilar basal insulin
This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.